1263 related articles for article (PubMed ID: 28654243)
1. Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.
Zielonka J; Joseph J; Sikora A; Hardy M; Ouari O; Vasquez-Vivar J; Cheng G; Lopez M; Kalyanaraman B
Chem Rev; 2017 Aug; 117(15):10043-10120. PubMed ID: 28654243
[TBL] [Abstract][Full Text] [Related]
2. Mitochondria as a Novel Target for Cancer Chemoprevention: Emergence of Mitochondrial-targeting Agents.
Huang M; Myers CR; Wang Y; You M
Cancer Prev Res (Phila); 2021 Mar; 14(3):285-306. PubMed ID: 33303695
[TBL] [Abstract][Full Text] [Related]
3. A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds.
Kalyanaraman B; Cheng G; Hardy M; Ouari O; Lopez M; Joseph J; Zielonka J; Dwinell MB
Redox Biol; 2018 Apr; 14():316-327. PubMed ID: 29017115
[TBL] [Abstract][Full Text] [Related]
4. TPP-based conjugates: potential targeting ligands.
Batheja S; Gupta S; Tejavath KK; Gupta U
Drug Discov Today; 2024 Jun; 29(6):103983. PubMed ID: 38641237
[TBL] [Abstract][Full Text] [Related]
5. Triphenylphosphonium (TPP)-Based Antioxidants: A New Perspective on Antioxidant Design.
Wang JY; Li JQ; Xiao YM; Fu B; Qin ZH
ChemMedChem; 2020 Mar; 15(5):404-410. PubMed ID: 32020724
[TBL] [Abstract][Full Text] [Related]
6. Conjugation of Triphenylphosphonium Cation to Hydrophobic Moieties to Prepare Mitochondria-Targeting Nanocarriers.
Guzman-Villanueva D; Mendiola MR; Nguyen HX; Yambao F; Yu N; Weissig V
Methods Mol Biol; 2019; 2000():183-189. PubMed ID: 31148015
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria-Targeted Lupane Triterpenoid Derivatives and Their Selective Apoptosis-Inducing Anticancer Mechanisms.
Ye Y; Zhang T; Yuan H; Li D; Lou H; Fan P
J Med Chem; 2017 Jul; 60(14):6353-6363. PubMed ID: 28671831
[TBL] [Abstract][Full Text] [Related]
8. Triphenylphosphonium-conjugated glycol chitosan microspheres for mitochondria-targeted drug delivery.
Lee YH; Park HI; Chang WS; Choi JS
Int J Biol Macromol; 2021 Jan; 167():35-45. PubMed ID: 33227331
[TBL] [Abstract][Full Text] [Related]
9. Rapid uptake of lipophilic triphenylphosphonium cations by mitochondria in vivo following intravenous injection: implications for mitochondria-specific therapies and probes.
Porteous CM; Logan A; Evans C; Ledgerwood EC; Menon DK; Aigbirhio F; Smith RA; Murphy MP
Biochim Biophys Acta; 2010 Sep; 1800(9):1009-17. PubMed ID: 20621583
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial-targeted Hsp90 C-terminal inhibitors manifest anti-proliferative activity.
Zhang Z; Banerjee M; Davis RE; Blagg BSJ
Bioorg Med Chem Lett; 2019 Nov; 29(22):126676. PubMed ID: 31591016
[TBL] [Abstract][Full Text] [Related]
11. Thermoresponsive drug delivery to mitochondria in vivo.
Ruan L; Zhou M; Chen J; Huang H; Zhang J; Sun H; Chai Z; Hu Y
Chem Commun (Camb); 2019 Dec; 55(97):14645-14648. PubMed ID: 31746851
[TBL] [Abstract][Full Text] [Related]
12. Peptide-Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria.
Jean SR; Ahmed M; Lei EK; Wisnovsky SP; Kelley SO
Acc Chem Res; 2016 Sep; 49(9):1893-902. PubMed ID: 27529125
[TBL] [Abstract][Full Text] [Related]
13. Antitumor and toxicity study of mitochondria-targeted triptolide derivatives using triphenylphosphine (TPP
Song H; Xing W; Shi X; Zhang T; Lou H; Fan P
Bioorg Med Chem; 2021 Nov; 50():116466. PubMed ID: 34700239
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria-targeted drug delivery in cancers.
Cho H; Cho YY; Shim MS; Lee JY; Lee HS; Kang HC
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165808. PubMed ID: 32333953
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria-targeted triphenylphosphonium conjugated glycyrrhetinic acid derivatives as potent anticancer drugs.
Jin L; Dai L; Ji M; Wang H
Bioorg Chem; 2019 Apr; 85():179-190. PubMed ID: 30622010
[TBL] [Abstract][Full Text] [Related]
16. Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate.
Pathak RK; Marrache S; Harn DA; Dhar S
ACS Chem Biol; 2014 May; 9(5):1178-87. PubMed ID: 24617941
[TBL] [Abstract][Full Text] [Related]
17. Novel Strategies for Disrupting Cancer-Cell Functions with Mitochondria-Targeted Antitumor Drug-Loaded Nanoformulations.
S Allemailem K; Almatroudi A; Alsahli MA; Aljaghwani A; M El-Kady A; Rahmani AH; Khan AA
Int J Nanomedicine; 2021; 16():3907-3936. PubMed ID: 34135584
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-targeted small molecule therapeutics and probes.
Smith RA; Hartley RC; Murphy MP
Antioxid Redox Signal; 2011 Dec; 15(12):3021-38. PubMed ID: 21395490
[TBL] [Abstract][Full Text] [Related]
19. Medicinal Chemistry Targeting Mitochondria: From New Vehicles and Pharmacophore Groups to Old Drugs with Mitochondrial Activity.
Catalán M; Olmedo I; Faúndez J; Jara JA
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33217901
[TBL] [Abstract][Full Text] [Related]
20. Novel benzoate-lipophilic cations selectively induce cell death in human colorectal cancer cell lines.
Jara JA; Rojas D; Castro-Castillo V; Fuentes-Retamal S; Sandoval-Acuña C; Parra E; Pavani M; Maya JD; Ferreira J; Catalán M
Toxicol In Vitro; 2020 Jun; 65():104814. PubMed ID: 32112803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
